NCT00001050
Terminated
Not Applicable
Women's AIDS Cohort Study (WACS)
National Institute of Allergy and Infectious Diseases (NIAID)1 site in 1 country1,250 target enrollmentAugust 31, 2001
ConditionsHIV Infections
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- HIV Infections
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Enrollment
- 1250
- Locations
- 1
- Status
- Terminated
- Last Updated
- 20 years ago
Overview
Brief Summary
To study the effect of pregnancy, age, drug use, and coinfections on HIV progression rate. To document the prevalence, incidence, characteristics, and course of HIV infection and anogenital intraepithelial neoplasia among HIV-positive and HIV-negative women. To study the effect of HIV disease on gynecologic health including infections and reproductive function.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 2
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant WomenHIV InfectionsH1N1 Influenza VirusNCT00992017National Institute of Allergy and Infectious Diseases (NIAID)130
Completed
Not Applicable
A Study of HIV Levels During Pregnancy and After ChildbirthHIV InfectionsPregnancyNCT00041964National Institute of Allergy and Infectious Diseases (NIAID)129
Active, not recruiting
Not Applicable
Comorbidity and Aging With HIVHIV-1-infectionComorbidityAgeingNCT01466582Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1,148
Completed
Not Applicable
Prospective Cohort Evaluating Pregnancy Rates, PK Interactions Among HIV+ Women on EFV Initiating LNG Implant or DMPAHIV InfectionsNCT03153709University of North Carolina, Chapel Hill1,382
Completed
Not Applicable
Long Term Follow-Up of HIV Infected Patients Who Have Previously Participated in HIV Clinical TrialsHIV InfectionsNCT00183287National Institute of Allergy and Infectious Diseases (NIAID)150